018552776

DELTEX

---

September 2, 2021

Trademark Summary

The trademark application DELTEX was filed by In8bio, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 4, 2022, and it was registered by office on April 13, 2022 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Change of name and address of the trademark registration was recorded on October 10, 2021. Change of name and professional address of the trademark registration was recorded on October 13, 2021. Change of name and professional address of the trademark registration was recorded on August 6, 2024.

---

Goods And Services

• The mark was filed in class 42 with following description of goods:
  
  1. Medical research and development
  2. Research and development of pharmaceuticals
  3. Research and development in the field of bioengineering and genetic engineering
  4. Research and development of treatments and therapies in the field of oncology
  5. Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders
  6. Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders
  7. Molecular, cellular, and genetic research and development
  8. Development of processes and methods for the manufacturing and engineering of cells and molecules
  9. Development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical services
  2. Providing health information
  3. Providing health information in the field of bioengineering and genetic engineering
  4. Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment
  5. Medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders
  6. Therapeutic services and cell therapies for the treatment and prevention of cancer.